Search results
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 2 years agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 2 months agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Zacks via Yahoo Finance· 5 months agoFDA approves Merck's (MRK) Keytruda plus chemoradiotherapy (CRT) for patients with FIGO 2014 Stage...
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
Investor's Business Daily· 1 year agoIn the span of a month in late 2022, Merck gained a new chairman, announced a $1.35 billion takeover...
Drug offers lifeline to 1,600 women with rare aggressive form of breast cancer
Press Association News via AOL· 2 years agoHundreds of women are to benefit from a new breast cancer drug which targets one of the most...
Merck's (MRK) Keytruda for Liver Cancer to Undergo FDA Review
Zacks via Yahoo Finance· 1 year agoFDA accepts Merck's (MRK) supplemental biologics license application for Keytruda plus chemotherapy...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 3 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via AOL· 4 weeks agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's...
LA Times via Yahoo Finance· 1 year agoThe big drugmaker Merck wants to stifle Medicare's right to negotiate drug prices. (Mel Evans /...
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough...
Business Insider via Yahoo News· 2 years agoStéphane Bancel, the CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's cancer...